Skip to main navigation Skip to search Skip to main content

Sentinel lymph node biopsy for cutaneous squamous cell carcinoma on the head and neck

  • Alison B. Durham
  • , Lori Lowe
  • , Kelly M. Malloy
  • , Jonathan B. McHugh
  • , Carol R. Bradford
  • , Heather Chubb
  • , Timothy M. Johnson
  • , Scott A. McLean

Research output: Contribution to journalArticlepeer-review

Abstract

IMPORTANCE Metastasis of cutaneous squamous cell carcinoma (SCC) to the nodal basin is associated with a poor prognosis. The role of sentinel lymph node biopsy (SLNB) for regional staging in patients diagnosed with SCC is unclear. OBJECTIVE To evaluate a single institution's experience with use of SLNB for regional staging of SCC on the head and neck. DESIGN, SETTING, AND PARTICIPANTS A retrospective review of 53 patients whowere diagnosed with SCC on the head and neck, at high risk for nodal metastasis based on National Comprehensive Cancer Network (NCCN) risk factors, and treated with wide local excision (WLE) and SLNB from December 1, 2010, through January 30, 2015, in a single academic referral center was performed. The follow-up period ended November 5, 2015. Sentinel lymph node biopsy paraffin blocks were retrieved and processed retrospectively with serial sectioning and immunohistochemical analysis (IHC) in cases with nodal recurrence following a negative SLNB. MAIN OUTCOMES AND MEASURES Sentinel node (SN) identification rate, SLNB positivity rate, local recurrence, regional nodal recurrence, and distant recurrence. RESULTS In 53 patients with 54 tumors, the SN identification rate was 94%. The SLNB positivity rate was 11.3%. On more thorough tissue processing and IHC, metastatic SCC was identified in 2 of 5 (40%) cases previously deemed negative. After reclassification of these cases, the adjusted SLNB positivity rate was 15.1%. The adjusted rate of false omission was 7.1% (95%CI, 2%-19%). Nodal disease developed in 20.8%overall. Angiolymphatic invasion (Cohen d, 3.52; 95%CI, 1.83-5.21), perineural invasion (Cohen d, 0.81; 95%CI, 0.09-1.52), and clinical size (Cohen d, 0.83; 95%CI, 0.05-1.63) were associated with the presence of nodal disease. CONCLUSIONS AND RELEVANCE Rigorous study of SLNB for cutaneous SCC incorporating prospectively-collected comprehensive data sets based on standardized treatment algorithms is justified with potential to modify clinical practice. Our study demonstrates the critical importance of serial sectioning and IHC of the SLNB specimen for accurate diagnosis. Use of the NCCN guidelinesmay facilitate identification of patients with SCC at high risk for nodal metastasis.

Original languageEnglish (US)
Pages (from-to)1171-1176
Number of pages6
JournalJAMA Otolaryngology - Head and Neck Surgery
Volume142
Issue number12
DOIs
StatePublished - Dec 1 2016
Externally publishedYes

Bibliographical note

Publisher Copyright:
Copyright 2016 American Medical Association. All rights reserved.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Sentinel lymph node biopsy for cutaneous squamous cell carcinoma on the head and neck'. Together they form a unique fingerprint.

Cite this